Frequently Asked Questions: MHRA and JCVI guidance on AstraZeneca COVID-19 vaccine and very rare clotting disorders

Published on: 15 April 2021
Last modified on: 10 March 2022

• Coronavirus
• COVID-19

Further opportunity for community pharmacy to contribute to the COVID-19 vaccination programme – extended in specific areas

Published on: 14 April 2021
Last modified on: 15 March 2022

• Coronavirus
• COVID-19

Next phase of NHS COVID-19 vaccination campaign

Published on: 13 April 2021
Last modified on: 10 March 2022

• Coronavirus
• COVID-19

MHRA and JCVI announcement regarding AstraZeneca Vaccine and next steps

Published on: 7 April 2021
Last modified on: 10 March 2022

• Coronavirus
• COVID-19

Vaccination of permanent adult household contacts of severely immunosuppressed individuals alongside JCVI priority cohort 6

Published on: 31 March 2021
Last modified on: 24 March 2022

• Coronavirus
• COVID-19

JCVI Cohort 6 – adult household contacts of adults with severe immunosuppression – Operational Guide

Published on: 31 March 2021
Last modified on: 18 March 2022

• Coronavirus
• COVID-19

Vaccination of adult household contacts of severely immunosuppressed individuals alongside JCVI priority Cohort 6 and completion of Cohorts 1-9

Published on: 31 March 2021
Last modified on: 18 March 2022

• Coronavirus
• COVID-19

Maximising vaccine uptake in underserved communities: a framework for systems, sites and local authorities leading vaccination delivery

Published on: 26 March 2021
Last modified on: 11 March 2022

• Coronavirus

NHS response to COVID-19: Transition to NHS level 3 incident

Published on: 25 March 2021
Last modified on: 22 March 2022

• Coronavirus
• COVID-19

Patient Car Parking

Published on: 23 March 2021
Last modified on: 22 March 2022

• Coronavirus
• COVID-19